| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Conventional release oral ointment (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Conventional release vapor ointment for inhalation (dose form) |
Has basic dose form (attribute) |
False |
Ointment |
Inferred relationship |
Some |
|
| Conventional release ear or eye or nose ointment (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Oromucosal ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Conventional release ointment for cutaneous spray (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Urethral ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Ointment for vapour inhalation |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Drug ointment, 0,2% (product) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Drug ointment, 2,5% (product) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Drug ointment, 0,25% (product) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Drug ointment, 1% (product) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Drug ointment, 0,05% (product) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Drug ointment, 0,1% |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Drug ointment, 0,025% (product) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| pommade ophtalmique |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Ear ointment |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Nasal ointment |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Conventional release ear or eye or nose ointment (dose form) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Vaginal ointment |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Rectal ointment |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Conventional release vapor ointment for inhalation (dose form) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Cutaneous ointment |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Conventional release ear or eye ointment (dose form) |
est un(e) (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Dexamethasone + neomycin sulfate 1mg/3.5mg ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Anthralin 10 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Catechin 15% topical ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Chamomile extracts 10.5% ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Miconazole 0.25%/zinc oxide 15%/white petrolatum 81.35% topical ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Hydrocortisone acetate + pramoxine hydrochloride 2.5%ww/1%ww ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Fluocinolone acetonide+clioquinol 0.025%/3% ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Gentamicin sulfate + prednisolone acetate 0.3%/0.6%ww ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Collagenase 250unit/g ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Nitrofurazone 0.2% ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Prednicarbate 1 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Coal tar 12%/sulfur 4%/salicylic acid 2% ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Dexamethasone + tobramycin 1mg/3mg ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Povidone iodine 100 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Halobetasol propionate 0.05% ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Desoxyribonuclease + fibrinolysin 6666unit/10unit ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Benzoic and salicylic acid ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unit ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Mineral oil 50 mg/g and white petrolatum 950 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Heparinoid+hyaluronidase 50/150units/g ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Mineral oil 500 mg/g and white petrolatum 500 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Paraffin ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Nystatin + triamcinolone acetonide 100000unt/1mg ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Anthralin ointment |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Nystatin + triamcinolone acetonide 10000unt/1mg ointment (product) |
a une forme pharmaceutique (attribut) |
False |
Ointment |
Inferred relationship |
Some |
|
| Nasal ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Rectal ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Vaginal ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Cutaneous ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| pommade ophtalmique |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Ear ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Conventional release transdermal ointment (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Gingival ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
| Conventional release ear or eye ointment (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|